 |
|
BIOISRAEL.com is the hub site of Israel’s
life science community. BioIsrael’s Internet portal and newsletter
link Israeli companies with the international biopharmaceutical
and financial communities. Aiming to accelerate strategic alliances
and promote investments, BioIsrael:
www.bioisrael.com
back to top |
|
|
 |
|
Bio-M is a financing service and consulting company
with the aim to promote the development of the BioTech-Region München.
It is the one-stop shop for start-up biotech companies
seeking financial support, business advice and the right contacts.
Bio-M has set up a finance program to provide promising biotechnology
companies with venture capital in the initial seed and start-up
phases.
www.bio-m.de
back to top |
|
|
 |
|
BioTOP is a joint initiative established by the federal
states of Berlin and Brandenburg as well as the regional industry.
The Aktionszentrum BioTOP is developing strategies aiming at a clear-cut
commercial vision for biotechnology in the Berlin-Brandenburg area.
Furthermore we offer various free services to support biotech start
up companies and those who wish to settle in the region.
The BioTOP-Aktionszentrum's team is at your disposal
for all matters regarding biotechnology in Berlin and Brandenburg:
- Consultation about and presentation of R&D
and infrastructure projects
- Assistance in the canvassing of national and international
biotechnology enterprises
- Business establishing support
- Evaluation of biotechnological projects for the
economy and banks
- Providing a contact pool and information service
for the biotech-site
- PR for biotechnology
On the BioTOP homepage (www.biotop.de)
you will find a comprehensive overview of Berlin-Brandenburg's biotech
scene. The searchable database BioInfooffers detailed profiles of
+150 biotech companies and of over 200 teams of scientists.
www.biotop.de
back to top |
|
|
 |
|
DIB is the German industry association for biotechnology,
supported by the German Chemical Industry Association (VCI) and
its Sector Associations for Pharmaceuticals, Diagnostics, Animal
Health, Medical Devices, Crop Protection and others. DIB’s
role is:
-
representing of interests of biotechnology
companies in contacts with politicians, government, various
agencies and institutions and the general public;
-
representing the interests of
the German biotechnology industry in Europe through active participation
in international associations such as EuropaBio;
Eligible for membership in DIB are member companies
of VCI and its Sector Associations which are engaged in research,
development and production or render services using biotechnological
methods. At present, DIB has more than 200 member companies engaged
in research and production of pharmaceuticals, diagnostics, agro-biotech
products, enzymes, food additives etc. DIB represents large, medium-sized,
and small enterprises.
DIB and its supporting organizations have quite a
number of specialized committees. They take care of:
- regulation of biotechnology (national and European
level)
- emerging biotech companies
- intellectual property
- pharmaceuticals
- agro-biotechnology
- regional aspects
DIB’s coordinates:
Deutsche Industrievereinigung Biotechnologie (DIB)
Dr. Jens Katzek, Managing Director
Karlstraße 21, 60329 Frankfurt
Tel: +49(0)69/2556-1459
Fax: +49(0)69/2556-1620
e-mail: katzek@vci.de
www.vci.de/dib
back to top |
 |
|
 |
|
Dimitri
F. Dimitriou, CEO
DyoDelta Biosciences specialises in partnerships
in the Pharma / Biotech sector. It provides best-practice in corporate
partnering through its management and associates. DyoDelta Biosciences’
concept is unique in terms of being not a consultancy but utilizing
a group of senior executives with actual deal-making experience
in the pharma and biotech industry at the corporate level, to instigate
collaborations on behalf of its clients/partners. DyoDelta Biosciences
covers Europe, the US and Japan, in guiding and supporting investors,
pharma and biotech companies in corporate deals, covering all aspects
of transactions in an integrated way including pre-qualifying identifying
suitable opportunities, market projections, commercial evaluation
and technical due diligence, deal structure, generating optimal
financial terms, negotiations and contract drafting and post-deal
management.
In addition, DyoDelta Biosciences has two other
distinct activities: 1) acting as a bio-incubator, licensing early-stage
promising projects from academia with the potential to lead to novel
pharmaceutical compounds and 2) introducing new pharmaceutical products
through its network of collaborators and licensees in Europe and
Asia.
www.dyodelta.com
back to top |
 |
|
 |
|
Noonan Russo Presence EURO RSCG is an international
PR consultancy providing strategic communications counsel to pharmaceutical,
healthcare and biotechnology companies. From our four locations
New York, London, San Francisco and San Diego our
integrated teams provide services spanning corporate communications,
investor and media relations, strategic marketing and product communications.
Since 1988 we have served clients from start-up to global leaders
and have expanded and enhanced our capabilities to address the challenges
within this sector. Our approach is to fully understand our clients
strategic needs and provide creative and innovative solutions to
ensure the transition from vision to reality.
www.nrp-euro.com
back to top |
 |
|
 |
|
Founded in 1992, Ronald Trahan Associates (RTA) Inc.
specializes in media and investor relations for big and small companies,
both public and private. The firm was founded to provide experienced
counsel in a timely fashion while garnering the right kind of attention
for clients, all at an affordable price. RTA's services include:
Strategic Counsel (corporate positioning); Media Relations (by-lined
articles, feature-story publicity, interview preparation, news management,
press kits, video news releases); Investor Relations (shareholder
communications, analyst meetings, broker/dealer campaigns, multimedia
and PowerPoint presentations, presentation coaching, individual
investor campaigns, annual reports); and Multimedia Services (streaming
audio, streaming video, Web site development, CD/ROM authoring,
video production, Web casting). Headquartered just outside of Boston,
RTA serves companies in the Biomedicine, Biotechnology, Drug Discovery,
Healthcare, Medical Technology, and Pharmaceutical industries.
Mailing address: 5 Walpole St., Norwood, MA 02062
Tel: 781-762-9782(9RTA); Fax: 781-769-9782(9RTA).
www.ronaldtrahan.com
back to top |
 |
|
 |
|
The Trout Group provides investor relations and
strategic advisory services to the life science industry. Founded
in 1995, our team advises both public and private companies in the
U.S., Canada and Europe. Trout prides itself on:
- Relationships with the corporate and investor
life sciences community
- The team’s diverse experience and knowledge
of the life sciences sector
- The ability to execute the strategies we develop
with our clients
Our team approach to managing brings together experience
in the financial, marketing and scientific fields to create a balanced
perspective on fulfilling a company's needs. We have meaningful
relationships with highly respected analysts, portfolio managers,
investment bankers and venture capitalists. These relationships,
along with the academic and professional background of our team,
have created a wealth of intellectual capital at Trout. We have
a global reach, with offices in New York and San Francisco, along
with extensive connections within the European and financial communities.
More than anything, The Trout Group is dedicated
to providing the support needed to develop the strategic plan for
a company and, more importantly, working to implement the plan.
www.troutgroup.com
back to top |
 |
|
 |
|
Zurich MedNet is a public information resource and
business development network serving the medical and biotechnology
community of the Greater Zurich Area, Switzerland. Comprising more
than 400 companies, universities, institutes, foundations, hospital
and research labs, Zurich MedNet is the single largest medical/biotech
cluster in continental Europe.
Zurich MedNet offers specific services like start-up
support, cooperations and strategic alliances, tech-transfer, venture
capital and joint marketing initiatives. Through its webportal www.zurichmednet.org,
it offers an open service platform for the virtual cluster community
of medical and biotechnologies.
In organizing and planning for its competitive future,
Zurich MedNet has formed a strategic alliance with the University
of Minnesota’s MBBNet, an information resource web portal
to that US State’s virtual biomedical and bioscience community.
Together, Zurich MedNet and MBBNet represent the world’s first
and largest medical/bio cluster/web portal alliance, linking research
and information resources for more than 1300 organizations. Further
alliances in other regions of the world will be established.
www.zurichmednet.org
back to top |
 |
|
 |
| |